Contact
|
Coordinator
Olivier Toussaint, PhD
Contact and information
Béatrice Rayet, PhD
LINK-AGE deputy coordinator
The University of Namur
URBC - 61, rue de Bruxelles
B-5000 Namur - Belgium
Tel: * 32 (0) 81 72 41 07
Fax: * 32 (0) 81 72 41 35
beatrice.rayet@fundp.ac.be
|
|
LINK-AGE
: coordination and consolidation of European biogerontology: en
route towards formation of a European college of biogerontology
|
What
is ageing research? |
"To add life to years, not years
to life" is an adage found on the cover page
of the first issue of the Journal of Biogerontology. This
sentence summarizes what the state of mind of ageing research
is in our days.
Ageing
is a progressive deterioration of physiological functions
that impairs the ability of an organism to maintain homeostasis
and makes as a consequence this organism more susceptible
to diseases and death. The nature and the progression of
these declines vary between species as well as between the
individuals of same specie. Life span among animals is indeed
highly diverse ranging from a few hours (adult form of Ephemera
insect) to 150 years (giant tortoise). This huge discrepancy
between animal species renders the discovery of the factors
underlying the ageing process and the determinants of the
maximal length of life, major scientific interests. |
During the last decades, human life expectancy in the industrialized
countries has remarkably increased, and the proportion of
aged people over 80 years old will continue to augment in
the following years. Although this is an essentially positive
outcome from multiple improvements in health care and socioeconomic
circumstances, it nevertheless presents a growing anxiety
for all member and associated states of the European Union
in terms of increasing prevalence of age-related health
problems and the growing financial implications for social
security including pensions costs.
Thus,
research that can lead to novel intervention to improve
quality of life at older age has the potential for enormous
impact in an ever-ageing society. Recent advances indicate
that it is possible to intervene positively in the mechanisms
that cause age-related frailty, disability and disease,
particularly by developing and exploiting the fields of
genomics (integrative analysis of genome, the carrier of
genetic information) and biotechnology for health in old
age. These fundamental advances in science and technology
offer exciting opportunities to extend the period of good
quality and healthy life as well as functional independence
for the elderly people, and to develop European industries
addressing the challenges of age.
|
Why
do we age?
Ageing
is often considered as being driven by a biological clock.
However, we need to keep in mind that ageing is hardly observable
in natural populations where death is mainly occurring at
early age from accidents, predation, starvation, infection,
cold and so on and so forth. This is only in protected environment
(laboratories for mice and rats, zoo for several animals
species or the protected western societies for humans) that
the life expectancy and the ageing process can be observed
and analysed. So in that context, it is difficult to explain
how a biological clock would have evolved under the natural
selection as the animals are not living in the
wild till an age at which the effects of the clock become
apparent. An important pressure is exerted on animals to
adapt to continuous changing life conditions and to assure
the dissemination of their genes to their offspring. So equilibrium exist
between the metabolic resources allocated to reproduction
on one hand and to the maintenance and repair of all physiological
functions on the other hand. When reproduction is ensured,
no energy is wasted on long-term maintenance of the adult
bodies: ageing process is launched. Although this may be
frightening for humans, organisms must come and go if evolution
is to work properly.
What
are the mechanisms underlying the ageing process?
Ageing
process is intricate and the comprehension of its molecular
mechanisms is still puzzling the research community. Although
today we may determine with better accuracy what are its
main driving components.
The
primary cause of ageing is the accumulation of damages at
the molecular, cellular and tissue level. All along the life,
numerous damages target macromolecules like DNA (deoxyribonucleic acid), proteins, lipids, e.g. all cellular constituents. Damages
in DNA results in mutations and may lead to several types of cancers.
Damages also accumulated into the protein constituents of
the cells which can contribute to several age-disorders
as cataracts, Alzheimer and Parkinson* diseases. The causes
of damages are multiples although, accumulation of evidences
identifies oxygen reactive species (=oxidative stress) as an important source of damages to
cell structure and function. The principal source of oxygen
reactive species in aerobic cells is the mitochondria, the respiration factory. During
the several hundred million years of evolution, aerobic
live evolved through adaptive processes for survival in
an oxygen environment. Indeed, organisms developed different
antioxidant mechanisms. Nevertheless, oxygen
reactive species appear early in the organism and during
ageing they do accumulate even more due to several mechanisms
as an increasing production in the mitochondria, a reduction
in oxidised protein and DNA repair and a decreased degradation
of damaged proteins. Other factors as human over-pollution
or inadequate nutrition also strongly influence the damage
processes.
|
So
we can say the primary control of the length of life is
the dynamics of body damages and repairs and that senescence
is caused by the accumulation within the organism of damages,
when longevity is secured by mechanisms of repair and maintenance.
Moreover,
and even though the ageing process is not genetically programmed,
a clear heritable component exists for human longevity through
genes that regulate these maintenance and repair functions
into the cells and tissues.
These
phenomenon of damages start to be understood and it is already
possible to intervene in the ageing process to alleviate
the age-related frailty and diseases. Europe needs to develop
a better coordination of these still fragmented researches
done on ageing. This coordination is required to gain a
better visibility of European ageing research and to participate
so to the educational, cultural, scientific and economical
future of Europe by the way of knowledge dissemination towards
the public and by industrial development of anti-ageing
products.
Nevertheless,
we have to keep in mind that our human societies need first
to resolve the huge inequalities existing between the haves
and the haves-not, and which concern life quality and life
expectancy. This is only in an ethically acceptable social
context that the development of innovative biotechnologies
including anti-ageing medicine will allow everyone to profit
a healthy long life. |
|
|
|